Diagnosis and Management of Complications of Invasive Coronary Angiography by Jong-Seon Park & Young-Jo Kim
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
9 
Diagnosis and Management of  
Complications of Invasive 
 Coronary Angiography 
Jong-Seon Park and Young-Jo Kim  
Yeungnam University Hospital  
Korea 
1. Introduction  
Since its introduction several decades ago, coronary angiography and intervention has 
become a widely and ever increasingly popular diagnostic and therapeutic modality. 
However, it is not devoid of occasional systemic and local complications, and their 
immediate detection and management are crucial to achieving a favourable clinical course. 
This chapter focuses on the mechanism, diagnosis and treatment of the inherent risks of 
coronary angiography and intervention.  
2. Systemic complications  
Coronary angiography and intervention comprise local procedures performed via a 
percutaneous vascular approach. Untoward hemodynamic and systemic hormonal changes 
and toxic effects of the contrast agents used might occur during and after procedures. 
Patient’s general status, comorbid conditions and degree of systemic atherosclerosis are the 
most important factors predisposing to the development of systemic complications. 
Effective pre-procedural preparation and immediate proper treatment help prevent event 
occurrence and its subsequent deterioration to permanent sequelae.   
2.1 Side effects of contrast agent 
Use of contrast agents has a long history since the introduction of X-ray technology in 1895, 
and progressive changes after Douglas Cameron of Minnesota recommended the use of 
sodium iodide for retrograde phelography reduced toxicity leading to current angiography 
practices. The side effects of contrast agents are related to their osmolarity, hydrophilicity 
and viscosity, and there currently are different kinds of contrast media available which can 
be classified according to their chemical characteristics (Table 1).  
Osmolarity is the most important characteristic of contrast agents, which thereby are 
classified into high-osmolar (∼2,000 mOsm/kg), low-osmolar (600∼800 mOsm/kg) and iso- 
osmolar (290 mOsm/kg) contrast media. Commonly, high osmolar contrast agents induce 
fluid shift into vessels, which can cause a febrile sensation and pain. Also, high osmolar 
contrast media take cellular fluid from cells including red blood cells and therefore lead to 
dehydration and morphological changes. Hemodilution and hypervolemia can further 
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aggravate heart failure when present. In the past 60 years, high–osmolar contrast media 
with osmolarity 5∼8 times higher than that of plasma have been replaced by low-osmolar 
contrast media having osmolarity 2∼3 times higher than that of plasma.  
 
Osmolarity Molecular 
structure 
Component Iodine 
concentration 
(mg/mL) 
Osmolarity 
(mOsmol/kg) 
Viscosity 
at 37oC 
(cps) 
High- 
osmolar 
Ionic 
monomer 
Sodium 
iothalamate 
Meglumine 
diatrizoate 
320-370 1,500∼2,100 2.75-5.0 
Low- 
osmolar 
Ionic 
dimer 
Meglumine 
ioxaglate 
320 580 6 
Iopamidol 
Iohexol 
Loversol 
Iopromide 
300 520-672 4.5-6.3 
Iso-
osmolar 
Nonionic 
dimer 
Iotrolan 240 320 8.1 
Iodixanol 320 290 11.4 
Table 1. Characteristics of contrast media 
Cell membranes consist of phospholipid bilayers which are resistant to hydrophilic 
molecules. Therefore hydrophilic contrast agents are safer than hydrophobic ones.  
Viscosity increases as iodine concentration increases and temperature decreases; therefore, 
contrast agents should be heated from room temperature to body temperature before use.  
Early ionic contrast agents were associated with high incidence of early systemic side effects 
such as nausea, urticaria, pain, and heat sensation by comparison to non-ionic agents. 
Therefore, ionic agents have been replaced with non-ionic agents. However, the incidence of 
late skin reaction, i.e., 24 hours after injection of non-ionic dimeric agents is relatively high 
as compared to monomeric agents (Sutton et al 2001).    
The side effects of contrast media are divided into anaphylactoid and non-anaphylactoid 
reactions. Most of the adverse effects occur within 20 minutes after administration of 
contrast agents. Therefore, the patient’s systemic symptoms, blood pressure, heart rate and 
rhythm, and respiratory status should be carefully monitored early after contrast injection. 
Furthermore, the catheterization laboratory always should be ready for cardiopulmonary 
resuscitation.    
2.1.1 Anaphylactoid reactions  
Anaphylactoid reaction is a life-threatening side-effect of contrast media which occurs 
within 20 minutes and requires immediate, intensive therapy; the incidence of use of high 
osmolar contrast agent is approximately 1∼3 % and a fatal reaction has been estimated at 0.9 
cases per 100,000 exposures (Krause 2010). The term anaphylactoid reaction refers to a 
syndrome that albeit clinically similar to anaphylaxis differs from true hypersensitivity 
reactions by mast cell or basophil degranulation which is independent from 
immunoglobulin-E mediation, not requiring previous sensitisation, and not consistently 
recurring in an experienced patients (Hong et al 2002). Mild symptoms include urticaria, 
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pruritus, dizziness, mild dyspnea, nausea and vomiting and these are usually self-limiting 
and resolving with minimal medical therapy. In severe cases, symptoms such as 
hypotension, bronchospasm, laryngeal edema, abdominal cramps, pulmonary edema, 
syncope, and serious arrhythmias can occur and lead to death and therefore require 
intensive treatment. In patients who are at high risk of an anaphylactoid reaction to contrast 
media, H1 antihistamines and corticosteroids prior to the administration of ionic contrast 
may be useful in preventing anaphylactoid reactions to contrast agents (Delaney et al 2006). 
The treatment of anaphylactoid reactions depends on the severity of symptoms and clinical 
findings. Monitoring of the respiratory status and oxygen concentration is very important. If 
mild bronchospasm occurs, patient can be treated with oxygen supplementation and/or 
bronchodilator inhalation. In moderate cases, 0.1-0.3 mL of 1:1000 epinephrine should be 
subcutaneously administered carefully, especially in patients with cardiac disease. In more 
severe cases, 1 mL of 1:10,000 epinephrine can be administered intravenously for 5 minutes, 
which can be repeated every 10 minutes. Additionally, antihistamines may be administered.   
Hypotension is another serious side effect of contrast agents. Immediate oxygen 
supplementation and isotonic fluid supplement is necessary, and if ineffective, dopamine at 
an infusion rate of 2-20 μgm/kg/min can be administered.  
2.1.2 Non-anaphylactoid reactions  
Early (<24 hours) and late (24 hours ∼ 7 days) reactions may occur after injection of contrast 
agents. The mechanisms of the late reactions are unknown and their manifestations are very 
diverse and non-specific, including flulike symptoms such as general weakness, headache, 
fever, chill, vomiting, abdominal pain, constipation or diarrhea, pruritus and rash. Most 
symptoms are self-limiting and respond well to symptomatic treatment and fluid 
administration.     
Hypotension and bradycardia as consequence of vasovagal stimulation associated with 
high-osmolar contrast infusion are common. Isotonic fluid and atropine administration 
(0.5∼1 mg, intravenously, repeated every 3-5 minutes) are effective in most cases.  Life 
threatening cardiac arrhythmias such as ventricular tachycardia and ventricular fibrillation 
can occur after rapid injection of contrast media, especially in patients with acute 
myocardial infarction. Careful ECG monitoring after first contrast injection and immediate 
cardioversion or defibrillation should be performed.  
Contrast-induced nephropathy (CIN), an important complication in the use of contrast 
media, is associated with increased frequency of late cardiovascular events after coronary 
intervention as well as increased risk of death. The commonly used definition of CIN is a 
rise in serum creatinine level of 0.5 mg/dL or a 25% increase from baseline value, assessed 
at 48 hours after angiography (Solomon et al 2010). The incidence of CIN in patients 
undergoing coronary intervention varies depending on the definition, preventive 
management, baseline renal function and procedures, and it ranges between 2∼37% 
(Solomon et al. 2010, Gruberg et al 2000). There are several known risk factors for CIN 
(Table 2). The type of contrast media used is one of the important factors for the 
development or aggravation of renal failure. A meta-analysis showed that low-osmolarity 
contrast media was associated with significantly lower rates of CIN than high-osmolarity 
contrast media, especially  in patients with pre-existing renal failure (Barrett et al 1993). 
Also, iso-osmolar contrast media have been shown to be associated with a lower risk of CIN 
than low-osmolar contrast media in patients with high risk for the development of CIN.   
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Patient comorbidities Diabetes mellitus 
Congestive heart failure 
Acute hypotension 
Anemia 
Myocardial infarction 
Nephrotoxic drugs 
Volume depletion 
Reduced renal function (eGFR <60 mL/min/1.73 m) 
Procedural factors Contrast volume 
Type of contrast  
Periprocedural hypotension 
Table 2. Risk factors for contrast-induced nephropathy(Solomon et al. 2010, McCullough 
2008) 
The pathophysiology of CIN remains unknown; however, it is believed to result from 
release of acute vasoconstrictors induced by adenosine, endothelin, prostaglandin leading to 
ischemic injury and death of renal tubular cells (McCullough 2008). Although more clinical 
studies are needed, some effective preventive measures have been suggested based on 
postulated mechanisms and clinical trial results (Table 3). Volume expansion is the easiest 
and most effective method although there are limited data on optimal solution and volume. 
Although many pharmacological agents including antioxidants, ascorbic acid, statins, 
prostaglandins, aminophylline/theophyllines and N-acetylcysteine (NAC) have been 
suggested for the prevention of CIN, none has been proven effective. Also, there are 
inconsistent data regarding the renal protective effect of hydration, N-acetylcysteine, and 
theophylline. Among them, NAC is considered as a cost effective and safe agent, and the 
combination of volume expansion and NAC is more effective than NAC alone (Briguori et al 
2007). A meta-analysis showed N-acetylcysteine as more renoprotective than hydration 
alone; theophylline also might reduce risk for contrast-induced nephropathy however the 
detected association did not achieve statistical significance (Kelly et al 2008). 
 
Pre- and post-procedure Hold nephrotoxic agents  
- Anti-inflammatory drugs 
- High dose diuretics 
- Aminoglycosides 
Volume expansion (Isotonic saline with/without 
bicarbonate solution) 
- 1.0 mL /kg/hr, 12 hours before and 12 hours 
after procedure 
- Urine flow : >150 mL/hr 
N-acetylcysteine  
- 1200 mg oral bid pre-and post-procedure 
During procedure Use iso- or low-osmolar contrast 
Lowest dose of contrast 
Post-procedure Dialysis and hemofiltration 
Table 3. Suggestive preventive measures for contrast-induced nephropathy in patients at 
risk 
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2.2 Cholesterol embolization syndrome 
Cholesterol embolization syndrome (CES), known as blue toe syndrome, is caused by 
systemic embolization of cholesterol crystals from aortic atherosclerotic plaques. CES is 
suggested by the gradual onset of peripheral cutaneous manifestations, livedo reticularis, 
accompanied by progressive increases in blood urea nitrogen and creatinine levels following 
an arterial catheterization procedure. The aortic plaques easily come off the aortic wall and 
embolize to the brain, eyes, kidneys and extremities. Eosinophilia which is present in up to 
80% of cases might be an important clue to early detection of cholesterol embolization 
syndrome (Wilson et al 1991). The clinical incidence is 0.09∼1.4%, varying according to the 
aggressiveness of procedures such as diagnostic angiography, coronary intervention and 
peripheral vascular intervention (Fukumoto et al 2003, Scolari et al 1996). Elevation of 
baseline plasma C-reactive protein (CRP) level is a risk factor independently associated with 
CES indicating an important association between systemic inflammation and CES 
(Fukumoto et al. 2003). The clinical presentation varies from asymptomatic to multi-organ 
failure. In-hospital mortality is 16% which is increased to 70∼90% in patients with diffuse 
embolism and multi-organ failure (Fine et al 1987). When CES is suspected, it is 
recommended to discontinue anticoagulation because several case reports have suggested 
that patients are more likely to develop CES when they are anticoagulated (Bruns et al 1978). 
Most of the treatments are supportive with symptomatic measures. 
2.3 Stroke  
The cerebral embolism rate associated with coronary angiography is dependent on the 
clinical characteristics of the patients, catheterization methods, imaging modalities for the 
diagnosis, and clinical severity. In one series, silent ischemic cerebral lesions detected by 
diffusion-weighted MRI were found in 5-22% patients after cardiac catheterization (Hamon 
et al 2006, Busing et al 2005). After diagnostic coronary angiography via femoral approach, 
stroke occurred in 0.11%, with a persistent neurological defect in only 0.04% (Ammann et al 
2003). Although radial access for coronary angiography is more prone than femoral access to 
generating more particulate cerebral microemboli which can pass the right middle cerebral 
artery, femoral and radial access are associated with similar rates of stroke.  
3. Local complications  
Local vascular puncture and closure necessary in all catheterization procedures can cause a 
variety of local complications, ranging from minor problems resolving with time to major 
complications with long-term sequelae. For the individual patient, the risk is dependent 
upon cardiovascular anatomy, the experience of the operator, and the type of procedure 
being performed. Immediate detection and proper treatment is vital for the prevention of 
catastrophic events. 
3.1 Local hematoma and bleeding 
Local bleeding and hematoma at the arterial puncture site are the most common 
complications of angiography. Small hematomas at the femoral puncture site are relatively 
common and usually insignificant; however, severe bleeding and hematoma requiring 
transfusion occur in 1.5∼5.8% of the cases. Most hematomas occur within 12 hours after 
sheath removal. Immediate bleeding occurring after sheath insertion is induced by arterial 
laceration at the site of the atherosclerotic vessel wall. Otherwise, delayed bleeding after 
sheath removal is due to inappropriate compression or coagulation disorders. Clinically, 
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risk factors are old age, female gender, high blood pressure, use of large sized sheaths, long 
procedural times and use of anticoagulants and glycoprotein IIb/IIIa receptor antagonists 
before or after procedures. Many arterial closure devices are available as an alternative to 
traditional mechanical compression. Although these devices have the potential to reduce the 
time to hemostasis, facilitate patient mobilization and decrease hospital length of stay, the 
incidence of access-site-related complications is similar or somewhat higher compared with 
mechanical compression (Nikolsky et al 2004, Biancari et al 2010). Local bleeding is 
transformed to hematoma, which spontaneously resolves in 1∼2 weeks in small hematomas, 
or in several weeks or months in large hematomas. Table 4 describes the general 
recommendations for postprocedural hemostasis after femoral artery access listed in the 
American College of Cardiology/Society for Cardiac Angiography and Interventions 
Clinical Expert Consensus Document on Cardiac Catheterization Laboratory Standards 
(Bashore et al 2001). 
 
Situation      Recommendation 
Following hemostatic closure device 1–2 h recumbent in position of comfort, 
then ambulate 3 30 min before discharge 
  Following removal of venous sheath  1 h with leg straight, then ambulate 3 30 
min before discharge 
Following removal of femoral arterial 
sheath (ACT ,175 s) 
Manual compression    10–20 min (until hemostasis achieved) 
Clamp     15 min to 1 h to achieve hemostasis 
Bedrest     Leg straight, slight head elevation X 2–6 h 
Ambulation    30 min to 1 h before discharge 
Table 4. General recommendations regarding postprocedural hemostasis after prior femoral 
artery access(Bashore et al. 2001) 
3.2 Pseudoaneurysm  
After removal of the sheath and compression, the puncture site is surrounded and blocked 
by local hematoma. Inappropriate compression favours come-and-go blood flow between 
artery lumen and aneurysm surrounded by hematoma. Femoral peudoaneurysm is the 
second most  common complication occurring in 0.1% to 0.2% of diagnostic angiograms and 
3.5% to 5.5% of interventional procedures (Demirbas et al 2005, Kronzon 1997). If hemostasis 
is achieved using manual compression, the pseudoaneurysm rate is higher in superficial 
femoral artery than common femoral artery access, however rates are similar when using 
closure devices (Gutzeit et al 2011). In patients with acute coronary syndrome who are 
undergoing emergency angiography and possible intervention, pseudoaneurysm rate 
needing closure is lower in radial compared with femoral angiography (HR 0·30, 95% CI 
0·13—0·71; p=0·006) (Jolly et al 2011). Small femoral pseudoaneurysm is usually filled with 
clots and does not require treatment, however, larger femoral pseudoaneurysms may lead 
to secondary complications including rupture, local pain and compression of the adjacent 
femoral vein or nerve (Kronzon 1997). Color Doppler ultrasonography is the best diagnostic 
tool with a positive diagnostic rate of 95%, however other imaging modalities such as 3-
dimentional CT angiography and angiography are useful. Using color-Doppler 
ultrasonography, flow inside the aneurysm sac and the “to-and-fro flow” at the neck of the 
lesion is definitely diagnostic. Application of good external compression after sheath 
www.intechopen.com
 
Diagnosis and Management of Complications of Invasive Coronary Angiography 175 
removal, selecting a small-bore introducer and sheath removal at a low activated clotting 
time (<200 sec) are important factors preventing pseudoaneurysm. Ultrasonography guided 
compression of the communicating canal of the pseudoaneurysm stops the blood flow and 
leads to clotting and obliteration with a success rate of 84-93% in patients without 
anticoagulation (Lange et al 2001, Gabriel et al 2007, Schaub et al 1994). Ultrasound-guided 
thrombin injection is another effective means with a success rate of 97-100% (Schneider et al 
2009, Weinmann et al 2002). Other endovascular approaches, such as stent graft repair and 
coil embolization, are also available. Open surgical repair should be considered after non-
surgical procedure failure.  
 
 
Fig. 1. Doppler ultrasonography image showing a flow jet from superficial femoral artery to 
pseudoaneurysm surrounded by huge hematoma 
 
 
Fig. 2. Computerized tomographic (CT) findings of pseudoaneurysm in a patient who 
underwent coronary angiography. A: Contrast enhanced pseudoaneurysm (arrow) is seen at 
anterior aspect of the superficial femoral artery. B: Three-dimensional reconstruction of the 
same patient showing saccular pseudoaneurysm (arrow), superficial femoral artery and 
anteria profunda femoris.   
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Fig. 3. Angiographic findings of pseudoaneurysm before (A) and after (B) coil embolization.  
3.3 Arteriovenous fistula 
Although iatrogenic femoral arteriovenous fistula is very rare with an incidence of 0.22%, it 
is a significant complication after femoral puncture technique (Sidawy et al 1993). The 
fistulas originating at the superficial femoral artery or at the profunda femoris artery drain 
to the superficial femoral, profunda femoris vein or its lateral circumflex branch. Below the 
femoral artery bifurcation, profunda femoralis vein crosses laterally behind the proximal 
superficial femoral artery and then lies in a posterior location to the profunda femoris 
artery. Therefore, it is important to avoid a low groin puncture by identifying the level of 
the inguinal ligament or localizing the distal half of the femoral head by fluoroscopy 
(Sidawy et al. 1993, Lamar R 1990). Early angiography and surgical correction are 
recommended for optimal results.  
3.4 Retroperitoneal hematoma  
Retroperitoneal hematoma occurs in less than 1% of cases of percutaneous coronary 
intervention. Clinical signs and symptoms include decreased haematocrit, back or 
inguinal pain, abdominal pain, diaphoresis, bradycardia and hypotension. Early 
recognition of retroperitoneal hematoma is very important because the diagnosis is often 
delayed as symptoms are nonspecific and difficult to recognize because blood silently 
tracks in the loose retroperitoneal fatty tissue. Factors predisposing to retroperitoneal 
hematoma are female gender, low body surface area, and higher femoral artery puncture 
(Farouque et al 2005). It can be easily detected on computerized tomography as an 
abnormal, high-density soft-tissue mass originating at the puncture site and contiguous 
with the retroperitoneum with resultant compression or distortion of the normal 
retroperitoneal structures. There is lack of clinical evidence for the best management of 
retroperitoneal haematoma. Inguinal compression is not effective in most cases. 
Retroperitoneal hematoma after femoral artery puncture can usually be treated by volume 
replacement, correction of coagulopathy and blood transfusion. A small subset of patients 
who are unresponsive to volume resuscitation require open repair of bleeding vessel 
(Kent et al 1994). 
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Fig. 4. Contrast-enhanced CT scan showing retropelvic hematoma one day after coronary 
angiography via right femoral artery 
3.5 Spasm 
Arterial spasm near the puncture site occurs when arterial size is too small for the sheath. 
The transradial approach for coronary angiography or angioplasty is increasingly being 
used as an alternative to femoral access due to its low rate of local complications. Arterial 
spasm is the most common complication of this technique especially in female patients. Use 
of hydrophilic coated sheath, but not long sheath, reduces the incidence of radial artery 
spasm during transradial coronary procedures (Rathore et al 2010). Intra-arterial or 
subcutaneous infusion of nitroglycerin reduces arterial spasm and facilitates introduction of 
catheters (Candemir et al 2009).  
4. Conclusion  
It is critical to make every attempt at minimizing occurrence of complications during and 
after coronary angiography and interventional procedures; beyond operator’s experience 
and the patient factors noted, this involves care and attentiveness. The impact of improved 
understanding and techniques in intervention should be added to management 
considerations. Coronary angiography and intervention is continuously evolving and 
knowledge acquired through clinical experience and availability of new devices should 
therefore allow safer procedures in the future.  
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Coronary artery disease (CAD) and its consequences are most important morbidity and mortality reasons in
the developed and developing countries. To prevent hard end-points, early definitive diagnosis and optimum
therapy play significant role. Novel advanced diagnostic tests which are biomarkers of inflammation, cell
adhesion, cell activation and imaging techniques provide to get the best result in the detection and
characterization of calcified or uncalcified atherosclerotic plaques. In spite of last developments in the imaging
methods, coronary catheterization is still frequently performed. Following the first cardiac catheterization
performed in 1844, date by date historical developments and the mechanics of cardiac catheterization
techniques, risks associated with coronary angiography, and also, preventions and treatments of possible
complications have been presented in this book. Other important issue is radiation exposure of patients and
staff during coronary angiography and scintigraphy. Radiation dose reduction techniques, general radiation
protection principles have been discussed in related chapters.
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